Study aims to determine whether MKK4 inhibitor c
Author: Michael
Led by figures from Oxford, Genomics England and
Companies join forces to discover and develop ne
Company’s latest product continuously monitors
Neurotech firm Somnee secures funding to scale p
Shift Bioscience identifies potent, pluripotency
New consumer longevity brand to support company’s clinical development of therapeutics based on proprietary resveratrol delivery platform. Clinical stage biotech Jupiter Neurosciences has officially launched a new line of consumer supplements designed to support health and performance, broadening its focus from clinical-stage pharmaceuticals into the consumer longevity market. The company is leveraging its proprietary micellar resveratrol delivery technology to the nutraceutical space, offering a range of supplements designed to enhance healthspan, cognitive clarity and metabolic resilience. The new supplement brand, called Nugevia, emerges from Jupiter’s primary focus on optimizing the therapeutic delivery of resveratrol to target neuroinflammation and combat neurodegenerative…
NFX General Partner Omri Drory wonders why more
Preclinical data suggest Telomir’s oral drug m
RLS-1496 enters Phase 1 aiming to modulate GPX4